The tolerability of efavirenz after nevirapine-related adverse events

被引:14
作者
Clarke, S
Harrington, P
Barry, M
Mulcahy, F
机构
[1] St James Hosp, Dept GenitoUrinary Med, Dublin 8, Ireland
[2] St James Hosp, Dept Clin Pharmacol, Dublin 8, Ireland
基金
美国国家卫生研究院;
关键词
D O I
10.1086/314026
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Eight patients who were infected with human immunodeficiency virus, and who had each sustained an adverse drug reaction while following a regimen including nevirapine, were switched to a regimen including efavirenz, None of the patients experienced adverse events identical to that which necessitated discontinuation of nevirapine, This study demonstrates that adverse events related to nevirapine are not a class-specific effect.
引用
收藏
页码:806 / 807
页数:2
相关论文
共 6 条
[1]   Efavirenz [J].
Adkins, JC ;
Noble, S .
DRUGS, 1998, 56 (06) :1055-1064
[2]  
CARPETER CC, 1998, JAMA-J AM MED ASSOC, V1, P78
[3]   HIGH-DOSE NEVIRAPINE - SAFETY, PHARMACOKINETICS, AND ANTIVIRAL EFFECT IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
HAVLIR, D ;
CHEESEMAN, SH ;
MCLAUGHLIN, M ;
MURPHY, R ;
ERICE, A ;
SPECTOR, SA ;
GREENOUGH, TC ;
SULLIVAN, JL ;
HALL, D ;
MYERS, M ;
LAMSON, M ;
RICHMAN, DD .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (03) :537-545
[4]   Antiretroviral drug resistance testing in adults with HIV infection -: Implications for clinical management [J].
Hirsch, MS ;
Conway, B ;
D'Aquila, RT ;
Johnson, VA ;
Brun-Vézinet, F ;
Clotet, B ;
Demeter, LM ;
Hammer, SM ;
Jacobsen, DM ;
Kuritzkes, DR ;
Loveday, C ;
Mellors, JW ;
Vella, S ;
Richman, DD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (24) :1984-1991
[5]  
MANION D, 1999, 6 C RETR OPP INF CHI
[6]   A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients - The INCAS trial [J].
Montaner, JSG ;
Reiss, P ;
Cooper, D ;
Vella, S ;
Harris, M ;
Conway, B ;
Wainberg, MA ;
Smith, D ;
Robinson, P ;
Hall, D ;
Myers, M ;
Lange, JMA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (12) :930-937